Publicaciones en colaboración con investigadores/as de Universitat Pompeu Fabra (10)

2023

  1. Automatic Tool for Pulmonary Artery Hemodynamic Assessment from 4D flow MRI

    Proceedings - International Symposium on Biomedical Imaging

  2. Binding of common organic UV-filters to the thyroid hormone transport protein transthyretin using in vitro and in silico studies: Potential implications in health.

    Environmental Research, Vol. 217

2020

  1. An Assay for Screening Potential Drug Candidates for Alzheimer's Disease That Act as Chaperones of the Transthyretin and Amyloid-β Peptides Interaction

    Chemistry - A European Journal, Vol. 26, Núm. 72, pp. 17462-17469

  2. Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer's Disease Drug Discovery

    Journal of Medicinal Chemistry, Vol. 63, Núm. 6, pp. 3205-3214

  3. Repurposing benzbromarone for familial amyloid polyneuropathy: A new transthyretin tetramer stabilizer

    International Journal of Molecular Sciences, Vol. 21, Núm. 19, pp. 1-16

  4. Undiscovered roles for transthyretin: From a transporter protein to a new therapeutic target for Alzheimer’s disease

    International Journal of Molecular Sciences, Vol. 21, Núm. 6

2019

  1. Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform

    Electrophoresis, Vol. 38, Núm. 18, pp. 2341-2348

2014

  1. Conformational analysis of peptides and glycopeptides derived from the consensus sequence for β-O-glucosylation

    Current Topics in Medicinal Chemistry, Vol. 14, Núm. 23, pp. 2712-2721

2007

  1. Monitoring gene therapy by external imaging of mRNA: Pilot study on murine erythropoietin

    Therapeutic Drug Monitoring, Vol. 29, Núm. 5, pp. 612-618